Mark Leschly

Insider Reports History

Entity
Individual
Location
Rho Capital Partners, Inc., 152 W 57 Th St 23 Rd Fl, New York, NY
Signature
/s/ Natella Novruzova - Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Leschly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ChargePoint Holdings, Inc. Director Common Stock 421K $588K $1.40 Jul 9, 2024 By LLC
ChargePoint Holdings, Inc. Director Common Stock 173K $241K $1.40 Jul 9, 2024 Direct
NGM BIOPHARMACEUTICALS INC Director Stock Option (Right to Buy) 19.6K Jun 8, 2021 Direct

Insider Reports Filed by Mark Leschly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CHPT ChargePoint Holdings, Inc. Jul 9, 2024 1 $0 4 Jul 11, 2024 Director
CHPT ChargePoint Holdings, Inc. Jul 18, 2023 1 $0 4 Jul 20, 2023 Director
CHPT ChargePoint Holdings, Inc. Jul 12, 2022 1 $0 4 Jul 14, 2022 Director
CHPT ChargePoint Holdings, Inc. Jul 12, 2021 1 $0 4 Jul 14, 2021 Director
CHPT ChargePoint Holdings, Inc. Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
NGM NGM BIOPHARMACEUTICALS INC Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
CHPT ChargePoint Holdings, Inc. May 27, 2021 1 $0 4 Jun 1, 2021 Director